BIOFIDELITY LTD

Active Cambridge

Research and experimental development on biotechnology

70 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
B

BIOFIDELITY LTD

Research and experimental development on biotechnology

Founded 15 Feb 2019 Active Cambridge, England 70 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 18 Aug 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 17 Mar 2026 Next due 28 Feb 2027 10 months remaining
Net assets £7M £7M 2024 year on year
Total assets £8M £3M 2024 year on year
Total Liabilities £712K £4M 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

330 Cambridge Science Park Milton Road Cambridge CB4 0WN England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BIOFIDELITY LTD (11830661), an active life sciences and medical technology company based in Cambridge, England. Incorporated 15 Feb 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£4.38M

Increased by £2.00M (+84%)

Net Assets

£7.10M

Increased by £6.53M (+1138%)

Total Liabilities

£712.39k

Decreased by £3.65M (-84%)

Turnover

N/A

Employees

70

Increased by 10 (+17%)

Debt Ratio

9%

Decreased by 79 (-90%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 5

Investors (8)

Investor NameInvestor SinceParticipating Rounds
Investor 8Sept 2019Seed
Investor 3Aug 2020Venture - Series Unknown, Series A, Series B
Investor 4Aug 2020Series A, Series B

Share Capital

Share Capital

Share allotments and capital structure

17 Allotments 29,298,610 Shares £358328.87m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
10 Jul 2025780,299£101k£0.129
3 Jun 202516,787,670£2.18m£0.13
7 Jan 202525,750£42k£1.64
9 Apr 20242,284,557£9.71m£4.25
9 Apr 2024180,014£0£0

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (96)

Longwall Venture Partners Llp (acting As Manager Of Lv3ecf And Longwall Ventures 3 Ecf (nominee) Limited)
13.7%
4,234,320
Richard Cameron
13.4%
4,130,204

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
17 Mar 2026Confirmation StatementConfirmation statement made on 14 Feb 2026 with updates
13 Mar 2026OfficersChange to director Mr Heiner Dreismann on 28 Feb 2026
26 Jan 2026CapitalAllotment of shares (GBP 308.9861) on 7 Jan 2025
8 Jan 2026CapitalAllotment of shares (GBP 308.9861) on 19 Aug 2025
18 Aug 2025AccountsAnnual accounts made up to 31 Dec 2024
17 Mar 2026 Confirmation Statement

Confirmation statement made on 14 Feb 2026 with updates

13 Mar 2026 Officers

Change to director Mr Heiner Dreismann on 28 Feb 2026

26 Jan 2026 Capital

Allotment of shares (GBP 308.9861) on 7 Jan 2025

8 Jan 2026 Capital

Allotment of shares (GBP 308.9861) on 19 Aug 2025

18 Aug 2025 Accounts

Annual accounts made up to 31 Dec 2024

Recent Activity

Latest Activity

Confirmation statement made on 14 Feb 2026 with updates

1 months ago on 17 Mar 2026

Change to director Mr Heiner Dreismann on 28 Feb 2026

1 months ago on 13 Mar 2026

Allotment of shares (GBP 308.9861) on 7 Jan 2025

3 months ago on 26 Jan 2026

Allotment of shares (GBP 308.9861) on 19 Aug 2025

3 months ago on 8 Jan 2026

Annual accounts made up to 31 Dec 2024

8 months ago on 18 Aug 2025